NGO · Germany · EU Transparency Register 429157047185-81
Counts here are a floor, never a total: they cover the 326 consultation files tracked so far (29,503 submissions, mostly 2025–26), so an organization's real filing history is larger, not smaller.
Among the 784 non-governmental organisations on this site, they rank #239 by legislative files engaged — a count of participation, not a measure of influence.
Self-declared to the EU Transparency Register (snapshot 30 Aug 2026).
Self-declared to the EU Transparency Register (snapshot 30 Aug 2026); cost bands are floors, not audited totals. Reused under Commission Decision 2011/833/EU.
Track German in PolicySpeak: request access →
Work at German Life Sciences Association (VBIO e. V.)? so we know who speaks for it.
German Life Sciences Association (VBIO e. V.) filed 3 positions between 11 Feb 2026 and 9 Jun 2026, across 3 of the 326 legislative files tracked here, attaching a full position paper 2 times.
I. Ground conflict: There is a need to protect scientific freedom and strategic protection of knowledge biotechnological knowledge as strategic knowledge. However, strategic governance, security interests and economic exploitation constraints interfere with the day-to-day life of research and can create contradictions with regard to the freedom of research and teaching. ‘II.
Filed in German · English published by the European Commission
The Biotech Act II is intended as an extension of the Biotech Act I to the field of application of industrial biotechnology and production. Both Acts focus on increasing the EU’s industrial competitiveness in biotechnology and biomanufacturing. This focus on late stages of the innovation chain is legitimate, but in the view of the German Life Sciences Association (VBIO) is not sufficient.
Filed in German · English published by the European Commission
Submission on behalf of the Alliance of University and Non-University Biodiversity Research in Germany and the Consortium of European Taxonomic Facilities (CETAF). >>> Please find additional remarks and recommendations attached (pdf). EFFECTIVENESS Q1 The ABS Reg has supported compliance with the Nagoya Protocol (NP) and to clarify individual and institutional responsibilities.
Looking for an argument rather than an organization? Search every submission for a phrase and see everyone who used it.
Organizations that also filed on at least two of the same consultations. A shared interest in the same dossiers — not evidence of coordination, and we do not suggest any.
Showing 5 of 87.
Everything on this page comes from German Life Sciences Association (VBIO e. V.)’s own submissions to the European Commission — we have added nothing and interpreted nothing. If something is wrong or out of date, email info@policyspeak.com and we will correct it. If you are an individual named in a record, our privacy policy sets out your rights to correction, objection and removal.
Quotes are verbatim from submissions published by the European Commission, trimmed to their opening passage and never summarized by a model. Organizations only, never individuals. Reused under Commission Decision 2011/833/EU; the European Commission is not liable for this reuse.